Ratios Reveal: Breaking Down LifeMD Inc (LFMD)’s Financial Health

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

LifeMD Inc (NASDAQ: LFMD) closed the day trading at $9.53 up 2.25% from the previous closing price of $9.32. In other words, the price has increased by $2.25 from its previous closing price. On the day, 0.59 million shares were traded. LFMD stock price reached its highest trading level at $9.87 during the session, while it also had its lowest trading level at $9.24.

Ratios:

For a better understanding of LFMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.74. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 0.99.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on November 30, 2023, initiated with a Buy rating and assigned the stock a target price of $10.

On July 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.

On July 03, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $9.H.C. Wainwright initiated its Buy rating on July 03, 2023, with a $9 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 31 ’23 when Velge Bertrand bought 60,000 shares for $3.93 per share. The transaction valued at 235,800 led to the insider holds 349,482 shares of the business.

Velge Bertrand bought 40,000 shares of LFMD for $150,400 on Aug 30 ’23. The Director now owns 289,482 shares after completing the transaction at $3.76 per share. On Aug 29 ’23, another insider, Velge Bertrand, who serves as the Director of the company, bought 32,072 shares for $3.58 each. As a result, the insider paid 114,818 and bolstered with 249,482 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 403023680 and an Enterprise Value of 389960128. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.46. Its current Enterprise Value per Revenue stands at 2.384 whereas that against EBITDA is -24.521.

Stock Price History:

The Beta on a monthly basis for LFMD is 1.21, which has changed by 4.3539324 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $12.88, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is -6.46%, while the 200-Day Moving Average is calculated to be 33.84%.

Shares Statistics:

Over the past 3-months, LFMD traded about 745.49K shares per day on average, while over the past 10 days, LFMD traded about 1083170 shares per day. A total of 38.26M shares are outstanding, with a floating share count of 32.69M. Insiders hold about 22.70% of the company’s shares, while institutions hold 30.98% stake in the company. Shares short for LFMD as of 1714435200 were 2562324 with a Short Ratio of 3.44, compared to 1711584000 on 2651524. Therefore, it implies a Short% of Shares Outstanding of 2562324 and a Short% of Float of 7.39.

Earnings Estimates

The performance of LifeMD Inc (LFMD) in the stock market is under the watchful eye of 4.0 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.16, while EPS last year was -$0.23. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.04 and low estimates of -$0.14.

Analysts are recommending an EPS of between -$0.22 and -$0.37 for the fiscal current year, implying an average EPS of -$0.3. EPS for the following year is -$0.18, with 4.0 analysts recommending between -$0.08 and -$0.31.

Revenue Estimates

5 analysts predict $48M in revenue for the current quarter. It ranges from a high estimate of $48.5M to a low estimate of $47.4M. As of the current estimate, LifeMD Inc’s year-ago sales were $35.95MFor the next quarter, 5 analysts are estimating revenue of $52.81M. There is a high estimate of $54.24M for the next quarter, whereas the lowest estimate is $51.26M.

A total of 5 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $208.91M, while the lowest revenue estimate was $200.02M, resulting in an average revenue estimate of $204.87M. In the same quarter a year ago, actual revenue was $152.55MBased on 5 analysts’ estimates, the company’s revenue will be $254.11M in the next fiscal year. The high estimate is $268.62M and the low estimate is $235.81M.

Most Popular

[the_ad id="945"]